In a recent move that has provoked uncertainty among health insurers, US Health Secretary Robert F. Kennedy Jr. has removed the Covid-19 vaccine from the Centers for Disease Control and Prevention’s (CDC) recommended immunization schedule. This decision particularly affects the coverage of the vaccine for healthy children and pregnant women, which was previously guaranteed under various private insurers and Medicaid expansion programs with no cost-sharing obligations.
Health insurers now face the challenging decision of whether to continue providing coverage for these groups in the absence of a recommendation on the CDC’s schedule. The schedule plays a crucial role in determining insurance coverage, as it is often used as a benchmark by insurers for deciding which vaccines to cover without additional costs to beneficiaries.
Kennedy’s action has left insurers in a position of uncertainty as they try to ascertain the implications for their coverage policies. As of the latest updates, the CDC has not provided additional guidance following the adjustment to the immunization schedule.
For more details on this evolving situation, refer to the full article available on Bloomberg Law, particularly the report by Nyah Phengsitthy and Lauren Clason that delves into the immediate implications and responses from different health insurance stakeholders.